Merger milestones: Cosciens Biopharma outlines future focus and strategy

25 Sep 2024 — Specialty biopharmaceutical, cosmeceutical, nutraceutical and pharmaceutical ingredients producer, Cosciens Biopharma reveals substantial progress toward its merger integration with biopharmaceutical player, Ceapro. The update includes planned changes to its management team, advancements across its current businesses and reports on its latest innovations.